Precision radiopharmaceutical diagnostic imaging procedures help identify abnormalities early in the progress of a disease —before many medical problems are apparent with other diagnostic tests. Despite the proven effectiveness of radiopharmaceuticals, such as Axumin and NETSPOT, countless patients are limited
Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy
This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of the publisher. Two sources report that they are responding to rapidly changing demands of their
Prostate cancer is a leading cause of death among US men. Advances in imaging are helping to detect it earlier – here is where prostate imaging is heading.
Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from
The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical
CONNECT WITH DMS
©2020 DMS Health Technologies
